Shijiazhuang Pharmaceutical Group Co., Ltd.
Shijiazhuang Pharmaceutical Group Co., Ltd. (Shijiazhuang Yiling Pharmaceutical Co., Ltd.) is an integrated biotechnology enterprise incorporated by Shijiazhuang Yiling Medical Holding Co., Ltd. in December 2012. The company is specialized in the R & D, production and sales of pharmaceuticals, biological products, health foods and medical services. It is one of the largest pharmaceutical enterprises in China with the most complete product serialization.
With a total area of 5.5 million square meters, the enterprise boasts complete modern production base and facilities, strong technical force and advanced production technology. The R&D center which is equipped with large-scale integrated solution for drug R & D, including biochemistry lab, exploration lab, compound synthesis lab, formulation lab, and storage and transfer lab, was awarded ISO9001 quality system certification and GMP certification.
At present, the group offers more than 80 products in three major proprietary brands: Yiling, Zhaoxin, and Xiyu; covering five major therapeutic areas: cardiology, neurology, endocrinology, oncology, and infectious diseases. It has reached strategic cooperation with more than 40 pharma companies and research institutes home and abroad.
The group focuses on enhancing the integration of five key competitive edges: scale, product structure, technology, supply-chain, and distribution. The scale competitiveness is based on the product serialization. The product structure competitiveness lies in the R&D of new drugs and the launching of new products in a timely manner. The technology advantage is grounded on filed of anti-liver fibrosis and anti-allergic reaction. The supply-chain advantage is based on the supply chain integration and efficiency of distribution. The market access advantage is reflected in intensified cooperation with industry-leading partners and global sales expansion.
In the future, Shijiazhuang Pharmaceutical Group Co., Ltd. will further enhance the clustering effect of its advantages in capital, information, resources and operation, and build the platform of globalizing production, operation, management, operation and branding, to achieve the integral modernization of global pharmaceutical enterprises. Weissman, the company name is committed to providing customers with safe, efficient, and high quality products and services.
